Diagnostic Performance of High-Frequency Ultrasound and Ultra-High-Frequency Ultrasound in Distinguishing Dermatofibrosarcoma Protuberans from Dermatofibroma: A 15-year Period Retrospective Analysis. [PDF]
Clin Cosmet Investig DermatolChen G +6 more
europepmc +1 more source
Highlighting a histopathological dilemma: atypical dermatofibrosarcoma protuberans diagnosed with multimodal dermoscopy. [PDF]
Skin Health DisH V +6 more
europepmc +1 more source
Fifth-Time Recurrence of Dermatofibrosarcoma Protuberans at Distinct Sites: A Rare Case Report. [PDF]
Clin Case RepTariq H, Javed H, Amin MHJ.
europepmc +1 more source
Bednar Tumor: A Rare Variant of Dermatofibrosarcoma Protuberans. [PDF]
CureusAlcocer Salas M +4 more
europepmc +1 more source
The 'CIED Team' Approach to Device-Related Complications. [PDF]
JACC Case RepMazzotta R +9 more
europepmc +1 more source
Novel FGL2::PDGFD and TGFBI::PDGFB Fusions Expand the Molecular Spectrum of Dermatofibrosarcoma Protuberans. [PDF]
Genes Chromosomes CancerCloutier JM +7 more
europepmc +1 more source
Dermatofibrosarcoma Protuberans at the Presumed Injection Site following CoronaVac COVID-19 Vaccination: A Case Report. [PDF]
Case Rep DermatolCao X, Yin R, Lv D, Xu Z, Hu Z, Tang B.
europepmc +1 more source
Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP)
Clinical Cancer Research, 2016 Item does not contain fulltextPURPOSE: To report on imatinib mesylate (IM) in patients with metastatic dermatofibrosarcoma protuberans (DFSP)/fibrosarcomatous (FS)-DFSP and on the impact of the treatment on tumor biology.
Chiara Castelli +2 more
exaly +2 more sources